Clinical Risk Prediction Model for Neoadjuvant Therapy in Resectable Esophageal Adenocarcinoma

GOALS AND BACKGROUND: Clinical staging with endoscopic ultrasound (EUS) and positron emission tomography (PET) is used to identify esophageal adenocarcinoma (EAC) patients with locally advanced disease and therefore, benefit from neoadjuvant therapy. However, EUS is operator dependent and subject to...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:J Clin Gastroenterol
Main Authors: Thota, Prashanthi N., Alkhayyat, Motasem, Cifuentes, Juan David Gomez, Haider, Mahnur, Bena, James, McMichael, John, Sohal, Davender P, Raja, Siva, Sanaka, Madhusudhan R.
Format: Artigo
Jezik:Inglês
Izdano: 2022
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8255331/
https://ncbi.nlm.nih.gov/pubmed/33405434
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/MCG.0000000000001489
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki